<DOC>
	<DOCNO>NCT02195843</DOCNO>
	<brief_summary>Heart failure rapidly grow cardiovascular condition develop country . Despite advance medical therapy , patient heart failure high risk death hospitalization . Cardiac Resynchronization Therapy - defibrillator ( CRT-D ) effective treatment heart failure . Despite high success rate CRT-D implant , possibility 10 % LV lead implant patient undergo trans-venous system implantation . In case , patient may undergo multiple procedure lead successfully implant . These implant failure due patient selection rather patient heart anatomy lead lead stability problem , phrenic nerve stimulation ( also call diaphragmatic stimulation ) poor electrical measurement . The phrenic nerve part heart run near area way large muscle , call diaphragm , separate lung space space contain stomach , liver , kidney internal organ abdomen . If lead electrode close nerve , cause small part contract give uncomfortable hiccup sensation . In many patient , phrenic nerve stimulation identify implant procedure movement postural change bring LV lead closer contact phrenic nerve . The investigation perform demonstrate equality performance two different modality optimization implant device Quartet lead , Empirical ( anatomical ) optimization Right Ventricle Left Ventricle ( RVLV ) conduction delay optimization .</brief_summary>
	<brief_title>Quadripolar Leads Management Heart Failure Patients Middle East</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Male female patient ≥ 18 year age Patient meet standard CRTD device indication ( Left Ventricular Ejection Fraction ( LVEF ) ≤ 35 % , QRS ≥ 120 m , New York Heart Association ( NYHA ) Class II , III ambulatory Class IV Heart Failure ( HF ) symptoms optimal recommend medical therapy ) implant St Jude Medical CRTD Patient willing provide write informed consent . Patient non leave bundle branch block ( RBBB , intraventricular delay ( IVCD ) Block ) Patient epicardial ventricular lead system . Patient limit intrinsic atrial activity ( ≤ 40 bpm ) . Patient persistent permanent Atrial Fibrillation . Patient 's life expectancy le 1 year Patient pregnant . Patient dependent IV inotropic agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>CRT-D</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>Middle East</keyword>
	<keyword>Quadripolar</keyword>
</DOC>